| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sr. VP Chief Financial Officer | Sr. VP, CFO | Sr.vp, Chief Financial Officer +3 more
1 company
Patrick Gregory S is a Sr. VP Chief Financial Officer at SUPERNUS PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $2.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 9, 2020 | SUPN Supernus Pharmaceuticals, Inc. | Sr. VP Chief Financial Officer | Sale+OE | 5,000 | $25.00 | $125,000.00 | -10.1% | |
| Nov 5, 2020 | SUPN Supernus Pharmaceuticals, Inc. | Sr. VP, CFO | Sale+OE | 5,000 | $23.00 | $115,000.00 | -10.1% | |
| Oct 15, 2020 | SUPN Supernus Pharmaceuticals, Inc. | Sr. VP, CFO | Sale+OE | 15,000 | $20.03 | $300,507.00 | -25.2% | |
| May 20, 2020 | SUPN Supernus Pharmaceuticals, Inc. | Sr.vp, Chief Financial Officer | Sale+OE | 15,000 | $25.03 | $375,379.50 | -24.6% | |
| May 8, 2020 | SUPN Supernus Pharmaceuticals, Inc. | Sr VP, Chief Financial Officer | Sale+OE | 15,000 | $23.14 | $347,034.00 | -24.6% | |
| Feb 27, 2019 | SUPN Supernus Pharmaceuticals, Inc. | Sr VP, Chief Financial Officer | Sale+OE | 20,000 | $41.53 | $830,650.00 | -29.5% | |
| Jul 2, 2018 | SUPN Supernus Pharmaceuticals, Inc. | VP, Chief Financial Officer | Sale+OE | 35,000 | $56.63 | $1,981,913.50 | -38.5% | |
| Jan 11, 2018 | SUPN Supernus Pharmaceuticals, Inc. | VP, Chief Financial Officer | Sale+OE | 50,000 | $43.56 | $2,178,145.00 | -47.2% | |
| Sep 8, 2017 | SUPN Supernus Pharmaceuticals, Inc. | VP, Chief Financial Officer | Sale+OE | 50,000 | $47.60 | $2,379,779.46 | -72.8% | |
| Apr 24, 2017 | SUPN Supernus Pharmaceuticals, Inc. | VP, Chief Financial Officer | Sale+OE | 54,000 | $32.37 | $1,747,872.00 | -99.6% |